Israel - Hospital Average Length of Stay for Carcinoma in Situ
Since 2014, Israel Hospital Average Length of Stay for Carcinoma in Situ jumped by 0.9% year on year. In 2019, the country was ranked number 5 among other countries in Hospital Average Length of Stay for Carcinoma in Situ at 4.8 Days. Israel is overtaken by Germany, which was ranked number 4 at 5.2 Days and is followed by Iceland with 4.3 Days. South Korea lead the ranking with 7.5 Days in 2019, that is a decrease of 2.6% compared to 2018. Iceland witnessed the best average annual growth at +10.6% per year, while New Zealand recorded the worst performance at -8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 4.80 |
| 2018 | 4.50 |
| 2017 | 5.40 |
| 2016 | 5.90 |
| 2015 | 4.50 |
Download all data from 2000 to 2019
How does Israel rank in Hospital Average Length of Stay for Carcinoma in Situ?
| # | 33 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
7.50 | 2019 | -2.6 % | +0.8 % | View data | |
| 2 |
#2
Slovakia
|
5.40 | 2019 | +0.0 % | +0.4 % | View data | |
| 4 |
#4
Germany
|
5.20 | 2019 | -1.9 % | -1.5 % | View data | |
| 5 |
#5
Israel
|
4.80 | 2019 | +6.7 % | +0.8 % | View data | |
| 6 |
#6
Iceland
|
4.30 | 2019 | +0.0 % | +10.6 % | View data | |